Serum Institute of India would sell the AstraZeneca COVID-19 vaccine to private hospitals at this price.
Serum Institute of India on Wednesday said that it would sell the AstraZeneca COVID-19 vaccine to private hospitals at this price.
In a report on Reuters, the Serum Institute of India said that it would sell the AstraZeneca COVID-19 vaccine to the Indian state governments at INR 400 (USD 5.30) per dose and to private hospitals at INR 600 (USD 7.95).
The Serum Institute of India said in a statement that it would encourage all corporate and private individuals to access the COVID-19 vaccines through private health systems and state-facilitated machinery.
“Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity. We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems,” the Serum Institute of India said in a statement.
Meanwhile, Philippine Food and Drug Administration (FDA) Director-General Eric Domingo said last Tuesday that the AstraZeneca COVID-19 vaccine topped the field in terms of the number of EUA (emergency use authorization) secured from regulatory authorities around the world.
During the Laging Handa briefing, Domingo revealed that the AstraZeneca COVID-19 vaccine — a COVID-19 vaccine jointly developed by AstraZeneca and Oxford University — secured 91 EUAs, including one from the WHO (World Health Organization).